文献速递肿瘤 PET/CT

18F-FMAU PET/CT细胞增殖显像辅助多参数MRI用于疑似前列腺癌影像引导活检

Cellular Proliferation Imaging With 18 F-FMAU PET/CT as Adjunct to mpMRI in Image-Guided Biopsy of Suspected Prostate Cancer.
PubMed 文献 · Clin Nucl Med · 2025-02-10

研究纳入17例临床疑似前列腺癌男性,行标准多参数MRI(mpMRI)和研究性18F-FMAU PET/CT,对22处影像引导活检组织行组织学检查(11处良性、6处ISUP 1级、5处ISUP 2级肿瘤)。mpMRI检测ISUP 1和ISUP 2前列腺癌的灵敏度分别为16.7%和100%,18F-FMAU PET/CT分别为50%和60%。作者认为18F-FMAU PET/CT可能作为mpMRI的辅助手段用于影像引导前列腺活检。

要点

  • 17例疑似前列腺癌男性行mpMRI与18F-FMAU PET/CT,22处活检组织行组织学检查。
  • mpMRI检测ISUP 1和ISUP 2肿瘤灵敏度分别为16.7%和100%。
  • 18F-FMAU PET/CT检测ISUP 1和ISUP 2肿瘤灵敏度分别为50%和60%。

核心结论

  • 作者认为18F-FMAU PET/CT可能作为mpMRI的辅助手段用于影像引导前列腺活检。

研究设计与样本

  • 17例临床疑似前列腺癌男性接受标准mpMRI和研究性18F-FMAU PET/CT。
  • 对22处影像引导活检所得组织样本行组织学检查。

主要发现

  • 22处活检组织学结果为11处良性、6处ISUP 1级肿瘤、5处ISUP 2级肿瘤。
  • mpMRI检测ISUP 1前列腺癌的灵敏度为16.7%,检测ISUP 2前列腺癌的灵敏度为100%。
  • 18F-FMAU PET/CT检测ISUP 1前列腺癌的灵敏度为50%,检测ISUP 2前列腺癌的灵敏度为60%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: We evaluated the potential diagnostic utility of PET with the cellular proliferation biomarker, 2'-deoxyl-2'-[ 18 F]fluoro-5-methyl-1-beta-D-arabinofuranosyluracil ( 18 F-FMAU), as an adjunct to multiparametric MRI (mpMRI), in localization of sites for image-guided biopsy in men with suspected prostate cancer. PATIENTS AND MATERIALS: Seventeen men with clinically suspected prostate cancer underwent standard mpMRI and investigational PET/CT with 18 F-FMAU. RESULTS: Tissue samples obtained from 22 image-guided biopsies were examined histologically. There were 11 benign, 6 ISUP grade 1, and 5 ISUP grade 2 tumors. The sensitivity for detection of ISUP 1 and ISUP 2 prostate cancer was 16.7% and 100% for mpMRI, and 50% and 60% for 18 F-FMAU PET/CT, respectively. CONCLUSIONS: 18 F-FMAU PET/CT may be a useful adjunct to mpMRI in image-guided prostate biopsy.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Jadvar H, Chen K, Mohamed P, et al. Cellular Proliferation Imaging With 18 F-FMAU PET/CT as Adjunct to mpMRI in Image-Guided Biopsy of Suspected Prostate Cancer. Clin Nucl Med. 2025. PMID: 39924745. doi:10.1097/RLU.0000000000005702

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。